Larvol Delta - Avacta-Reports-Updated-Phase-1-Clinical-Data-of-AVA6000-at-the-European-Society-for-Medical-Oncology-ESMO-Congress-Demonstrating-Multiple-Ongoing-Durable-Responses-in-Solid-Tumors

AVA6000 - Avacta

https://www.globenewswire.com/news-release/2024/09/14/2946231/0/en/Avacta-Reports-Updated-Phase-1-Clinical-Data-of-AVA6000-at-the-European-Society-for-Medical-Oncology-ESMO-Congress-Demonstrating-Multiple-Ongoing-Durable-Responses-in-Solid-Tumors.html

Sep 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next